Jane Street
KRYS icon

Jane Street’s Krystal Biotech KRYS Stock Holding History

Jane Street’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$355K Buy
+956
New +$286K ﹤0.01% 8828
2025
Q4 		– Sell
-3,381
Closed -$712K – 11819
2025
Q3 		$597K Buy
+3,381
New +$506K ﹤0.01% 7465
2025
Q2 		– Sell
-23,663
Closed -$3.48M – 10311
2025
Q1 		$4.27M Sell
23,663
-12,192
-34% -$2.05M ﹤0.01% 3170
2024
Q4 		$5.62M Buy
35,855
+17,674
+97% +$3.14M ﹤0.01% 2513
2024
Q3 		$3.31M Sell
18,181
-59,651
-77% -$11.5M ﹤0.01% 3541
2024
Q2 		$14.3M Sell
77,832
-15,913
-17% -$2.67M ﹤0.01% 1634
2024
Q1 		$16.7M Buy
93,745
+43,127
+85% +$5.99M ﹤0.01% 1335
2023
Q4 		$6.28M Sell
50,618
-24,508
-33% -$2.72M ﹤0.01% 2538
2023
Q3 		$8.71M Buy
75,126
+58,071
+340% +$7.08M ﹤0.01% 1937
2023
Q2 		$2M Sell
17,055
-7,051
-29% -$720K ﹤0.01% 4162
2023
Q1 		$1.93M Buy
+24,106
New +$1.89M ﹤0.01% 3889
2022
Q3 		– Sell
-4,509
Closed -$326K – 10099
2022
Q2 		$296K Sell
4,509
-15,818
-78% -$984K ﹤0.01% 7626
2022
Q1 		$1.35M Sell
20,327
-7,357
-27% -$459K ﹤0.01% 5490
2021
Q4 		$1.94M Buy
+27,684
New +$1.61M ﹤0.01% 4558
2021
Q1 		– Sell
-10,406
Closed -$624K – 9377
2020
Q4 		$624K Buy
+10,406
New +$520K ﹤0.01% 5409
2019
Q4 		– Sell
-6,939
Closed -$241K – 5449
2019
Q3 		$241K Buy
+6,939
New +$310K ﹤0.01% 4428

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jane Street's KRYS Position: Q2 2026 in Review

Jane Street opened a new position in Krystal Biotech (KRYS) in Q2 2026: 956 shares worth $355K. The stake represents ﹤0.01% of the portfolio and ranks #8828 among its holdings. This is a return to the name: Jane Street previously reported a position in KRYS as recently as Q3 2025.

Jane Street first reported a position in KRYS in Q3 2019 and has held it in 16 quarters since. The position peaked at $16.7M in Q1 2024. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Jane Street held 956 shares of Krystal Biotech worth $355K as of Q2 2026.
  • Krystal Biotech was a new Jane Street position in Q2 2026.
  • Krystal Biotech made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8828 holding.
  • Jane Street first reported a position in Krystal Biotech in Q3 2019 and has held it in 16 quarters since.
  • Jane Street's Krystal Biotech position peaked at $16.7M in Q1 2024.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.